More studies needed to determine effect on adverse clinical outcomes…. Kitty Kit Ting Cheung and colleagues from the Hong Kong Institute of Diabetes and Obesity, Prince of Wales Hospital, Hong Kong examined the implications of testosterone levels on cardiovascular CV risk factors, metabolic syndrome, and adverse clinical outcomes. The researchers …
Read More »Daily Yogurt Decreased Risk for Type 2 Diabetes
Cohorts included nearly 200,000 American medical professionals…. Mu Chen, a doctoral candidate at the Harvard School of Public Health, said in a press release, “Our study benefited from having such a large sample size, high rates of follow-up and repeated assessment of dietary and lifestyle factors.” Chen and colleagues evaluated …
Read More »ACCORD Analysis Suggests Intensive Glucose Lowering May Reduce Ischemic Cardiovascular Events
Higher A1C target recommended for patients over 65 with comorbidities… A team of Canadian and American researchers have analyzed data from the ACCORD trial to investigate whether the intensive lowering of glucose concentrations affects the risk of ischemic heart disease in patients with type 2 diabetes. The researchers assessed 10,251 …
Read More »Thiazolidinediones Not Linked to Bladder Cancer
Risk found unaffected by prolonged exposure to pioglitazone… According to a recent study of more than one million people published in Diabetologia, the diabetes medications pioglitazone (Actos) and rosiglitazone (Avandia) do not appear to have an association with bladder cancer. It is known that bladder tumors overexpress transcription factor called …
Read More »Midlife Diabetes Could Increase Risk of Cognitive Decline
Poor glucose control speeds progression of dementia… A new study by researchers from Johns Hopkins Bloomberg School of Public Health in Baltimore, MD, suggests that a midlife diagnosis of diabetes may accelerate the rate of cognitive decline over the following 20 years. Elizabeth Selvin, PhD, and her research team analyzed …
Read More »GLP-1 Receptor Activation Modulates Appetite, Rewards-Related Brain Areas
Study shows decrease in food intake and food-related brain responses… GLP-1 receptor agonists, currently used for the treatment of type 2 diabetes (T2DM), improve glycemic control and stimulate satiety, leading to decreases in food intake and body weight. Researchers hypothesized that food intake reduction after GLP-1 receptor activation is mediated …
Read More »Liraglutide Gets EU Positive Opinion for Diabetics with Renal Disease
GLP-1 agonist found to improved glycemic control, resulted in weight loss in type 2 adults with moderate renal impairment…
Read More »Mediterranean Diet Associated with Longevity Biomarker
Harvard researchers found that adherence to a Mediterranean diet was associated with longer telomeres, a biomarker of longevity… In a population based cohort study, researchers examined blood sample data from of 4,676 disease-free women from nested case-control studies within the Nurses’ Health Study who had had telomere length measured and …
Read More »Time-Restricted Eating May Protect Against Diabetes
Limiting food intake to 9-12 hours per day in mice was effective against high-fat, high-fructose and high-sucrose diets…
Read More »Inconsistent Evidence that Testosterone Increases CV Risk
EMA committee recommends that medication labels be changed to reflect more accurate data….
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.